Unavailability and shortages of antibiotics is an increasing problem for many countries with consequences both for patient safety and societal cost. At a WHO meeting 10-11 December 2018, a project funded by ReAct through Sida, the magnitude, causes and possible solutions of antibiotic shortages were discussed. To address causes such as few actors in the production, fragile supply chains, regulatory issues, procurement and business models, a comprehensive set of short-term and long-term solutions are needed.
A failing ecosystem
Securing access to effective antibiotics is not only a matter of innovation of new antibiotics, but also about sustainable production and supply of old antibiotics. Accessibility to antibiotics is a vulnerable ecosystem that is challenged by a range of problems, and this failing system must be rebuilt to find sustainable solutions to manage the problems.
ReAct’s commitment to find solutions
Last year ReAct together with leading experts pointed to the critical situation of unavailability of antibiotics in a Commentary in the Lancet Infectious Diseases. Building on this work, ReAct engaged with several stakeholders to continue exploring the causes and solutions to this problem. Through a grant from Sida, ReAct funded WHO to undertake an assessment of manufacturing capacity for selected antibiotics facing shortages risks in Europe. As part of this project, WHO and the Norwegian Directorate of Health and the Norwegian Institute of Public Health hosted a meeting in collaboration with ReAct.
Conclusions of the meeting
The meeting focused on market dynamics to assess the root causes of shortages, including transparency of the supply chain and prices. The meeting was a multi-stakeholder discussion that openly reflected on different sides of the perceived challenges and possible solutions.
Some of the key questions at the meeting were:
- What are the main obstacles and how can we overcome them?
- What are the most promising solutions?
- How can shortages of antibiotics be elevated to the political agenda?
Some ways forward identified at the meeting were:
- Improve demand forecast, early warnings, and communication.
- Improve access to use of old antibiotics by engaging professional societies and normative work.
- Improve political awareness on the real consequences and costs.
- Changes in regulatory practices and registration of old antibiotics.
- Ensure healthy and sustainable production, procurement and supply models.
These are high-level ideas that will require further consideration and evidence collection and taken forward as a package of actions to manage the root causes of the problem.
Read meeting report:
Meeting Report Antibiotic Shortages: Magnitude, Causes and Possible Solutions. Norwegian Directorate of Health, Oslo, Norway 10-11 December 2018. Geneva, World Health Organization; 2019. WHO/MVP/EMP/IAU/2019.02
Previous article on the topic: Unavailability of old antibiotics is threatening effective treatment of common bacterial infections.
More news and opinion
- ReAct’s 2019 wrap up and 2020 expectations
- Blog post by UNDP and ReAct: Antimicrobial resistance: An emerging crisis
- Water, sanitation and hygiene services critical to curbing antibiotic quick fix
- Diagnostics: Antibiotic susceptibility
- ReAct highlights during World Antibiotic Awareness week 2019
- 2019 AMR photo competition prizes announced
- Launch of UNICEF’s institutional guidance on antimicrobial resistance
- Proposed ban on colistin for animal use announced in Indonesia
- School children led celebration of World Toilet Day and World Antibiotic Awareness Week
- 10 Innovate4AMR-winning teams enjoyed 3-day workshop in Geneva
- After 4 collaborative meeting days: Actions for the future in Latin America
- Four key points from joint comments to One Health Global Leaders Group on AMR
- Why are children more vulnerable to AMR?
- Dr Yoel Lubell, Health Economist, on Thailand, AMR, UCH and cultural factors driving AMR
- UHC and AMR: The Thai Experience
- Why do effective antibiotics matter for quality of care and patient safety?
- New ReAct policy brief: Antimicrobial resistance and universal health coverage – What’s the deal?
- Three key takeaways from the ReAct Africa conference
- Diagnostics: Species identification
- AMR-specific indicator proposed for monitoring Sustainable Development Goals
- Five focus areas at the 2nd Ministerial Conference on AMR hosted by the Netherlands
- Safety concerns of fecal microbiota transplants
- Upcoming ReAct Africa Conference: universal health coverage and antimicrobial resistance in focus
- Mother Earth conference in Argentina – the environment in focus
- Diagnostics: What are we talking about?
- Connecting global to local civil-society-agenda on AMR at CSO convening in Geneva
- ReAct colleagues featured in WHO Bulletin as leading profiles in the work on reacting to antibiotic resistance
- RAN stakeholder at WHO IPC consultation – for standards and guidelines in African Union member states
- WHA conversation on Antibiotic Resistance as a Global Development Problem co-organized by ReAct
- 8 insights from ReAct Asia Pacific project on antibiotic stewardship in secondary level hospitals in India
- Open letter to UN Member States from former IACG members Anthony So and Otto Cars
- ReAct UHC Intervention at UNGA Multi-stakeholder Hearing for High-level Meeting on UHC
- ReAct Latin America honors Earth Day
- Medicines Patent Pool’s view on the role of licenses for antibiotics – World Intellectual Property Day
- Second time for Innovate4AMR competition!
- World Health Day 2019: Universal Health Coverage
- Diagnostics: Constraints for successful implementation
- Antibiotic Shortages: magnitude, causes and possible solutions: A new WHO meeting report
- Erry Setyawan, FAO, on Indonesian NAP: We need to work together to make it possible to manage AMR
- ReAct’s new 5-year strategic plan receives funding from Sida
- How infections spread and how to stop them
- Generating data for policy and practice